UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001571
Receipt number R000001894
Scientific Title Postmastectomy chemoradiation therapy(weekly paclitaxel) after adjuvant or neoadjuvant chemothrapy in breast cancer : A phase 1 trial
Date of disclosure of the study information 2008/12/15
Last modified on 2013/06/19 10:02:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Postmastectomy chemoradiation therapy(weekly paclitaxel) after adjuvant or neoadjuvant chemothrapy in breast cancer : A phase 1 trial

Acronym

Phase 1 trial of postmastectomy chemoradiation

Scientific Title

Postmastectomy chemoradiation therapy(weekly paclitaxel) after adjuvant or neoadjuvant chemothrapy in breast cancer : A phase 1 trial

Scientific Title:Acronym

Phase 1 trial of postmastectomy chemoradiation

Region

Japan


Condition

Condition

breast cancer

Classification by specialty

Hematology and clinical oncology Breast surgery Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To decide a maximum tolerated dose of weekly paclitaxel with concurrent radiation therapy

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Phase I


Assessment

Primary outcomes

The decision of a maximum tolerated dose of weekly paclitaxel with concurrent radiation therapy

Key secondary outcomes

The decisin of a recommended dose of weekly paclitaxel with concurrent radiation therapy and confirmation of adverse reaction


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Weekly paclitaxel with concurrent radiation therapy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Female

Key inclusion criteria

The subjects of this study were the patients who were judged as meeting all the following conditions by investigators.
1)Histological doagnosis was breast cancer.
2)Age 20-75 years old
3)Underwent complete postomastectomy
4)>=4 positive axillary nodes,1-3 positive axillary nodes with or without tumor >5cm,positive axillary nodes before or after neoadjuvant chemotherapy,T4a or N3 and so someone required postomastectomy radiation therapy by attending physician
5)Having no major organ dysfunction
Neutrophils>=1500/mm3
Platelets>=100000/mm3
Hemoglobin>=9.0mg/dL
Creatinine<=1.5mg/dL
ALT,AST<=100IU/mL
Bilirubin<=1.5mg/dL
Physically normal ECG
Physically normal UCG
Chest Xp:lung field clear
6)Without serious complication and active second primary cancer
7)ECOG performance status 0-1
8)Having a life expectancy of >= 3 months
9)Provided written consent at the start of the study




Key exclusion criteria

This study excludes the patients who are judged as being contrary to every condition of the following conditions by investigators.
1)Severe pleural effusion,pleural effusion or ascites
2)Congestive heart failure, coronary insufficiency, acute myocardial infarction within 6 months
3)Cerebrovascular accident within 6 months
4)Poorly controlled diabetes or treated with insulin
5)Poorly controlled hypertension
6)Active infection
7)Pregnant, lactating, and probably pregnant patients, and patients who want to become pregnant after the study period
8)Psychological distress
9)Other patients judged as being inappropriate for the subjects of the study by attending physician

Target sample size

12


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuichi Ando

Organization

Nagoya university hospital

Division name

Chemotherapeutics

Zip code


Address

65,tsurumai cho,shouwa ku,nagoya city

TEL

052-744-1902

Email



Public contact

Name of contact person

1st name
Middle name
Last name Sachi Morita

Organization

Nagoya university hospital

Division name

Chemotherapeutics

Zip code


Address


TEL

052-744-1902

Homepage URL


Email



Sponsor or person

Institute

Nagoya university hospital

Institute

Department

Personal name



Funding Source

Organization

nothing

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

名古屋大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2008 Year 12 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 08 Month 18 Day

Date of IRB


Anticipated trial start date

2009 Year 01 Month 01 Day

Last follow-up date

2013 Year 05 Month 30 Day

Date of closure to data entry

2013 Year 05 Month 30 Day

Date trial data considered complete

2013 Year 05 Month 30 Day

Date analysis concluded

2013 Year 06 Month 30 Day


Other

Other related information



Management information

Registered date

2008 Year 12 Month 12 Day

Last modified on

2013 Year 06 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001894


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name